Cdk1: the dominant sibling of Cdk2

被引:0
|
作者
Tarig Bashir
Michele Pagano
机构
[1] New York University School of Medicine and NYU Cancer Institute,Department of Pathology
[2] MSB 599,undefined
来源
Nature Cell Biology | 2005年 / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cdk2 is thought to regulate entry into S phase, whereas Cdk1 controls the initiation of mitosis. New evidence shows that Cdk1 is equally capable of promoting the G1/S transition in Cdk2−/− cells, raising the question as to whether Cdk1 constitutes the predominant cyclin-dependent kinase in mammalian cells, or only compensates for Cdk2 function when it is compromised.
引用
收藏
页码:779 / 781
页数:2
相关论文
共 50 条
  • [21] 胃癌中CDK1和CDK2的表达及预后意义
    颜伟
    张永红
    何乐亚
    魏欣
    陶德定
    胡俊波
    龚建平
    中国组织化学与细胞化学杂志, 2010, 19 (02) : 165 - 167
  • [22] Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
    Satoshi Nakayama
    Yasuhiro Torikoshi
    Takeshi Takahashi
    Tomokazu Yoshida
    Tamotsu Sudo
    Tomoko Matsushima
    Yuko Kawasaki
    Aya Katayama
    Keigo Gohda
    Gabriel N Hortobagyi
    Shinzaburo Noguchi
    Toshiyuki Sakai
    Hideki Ishihara
    Naoto T Ueno
    Breast Cancer Research, 11
  • [23] Cdk1 and Cdk2 activity levels determine the efficiency of replication origin firing in Xenopus
    Krasinska, Liliana
    Besnard, Emilie
    Cot, Emilie
    Dohet, Christiane
    Mechali, Marcel
    Lemaitre, Jean-Marc
    Fisher, Daniel
    EMBO JOURNAL, 2008, 27 (05): : 758 - 769
  • [24] Rational design of potent GSK3β inhibitors with selectivity for Cdk1 and Cdk2
    Lesuisse, Dominique
    Dutruc-Rosset, Gilles
    Tiraboschi, Gilles
    Dreyer, Matthias K.
    Maignan, Sebastien
    Chevalier, Alain
    Halley, Frank
    Bertrand, Philippe
    Burgevin, Marie-Claude
    Quarteronet, Dominique
    Rooney, Thomas
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 1985 - 1989
  • [25] RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2
    Gonzalez, Laura
    Nebreda, Angel R.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 107 : 21 - 27
  • [26] CDK2 and CDK1 specific activities: A novel prognostic indicator in early breast cancer
    Kim, S.
    Masuda, N.
    Inaji, H.
    Yoshidome, K.
    Tsujimoto, M.
    Akiyama, F.
    Ishihara, H.
    Hortobagyi, G. N.
    Ueno, N. T.
    Noguchi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Yeast as a model system to screen purine derivatives against human CDK1 and CDK2 kinases
    Mayi, Therese
    Facca, Celine
    Anne, Sandrine
    Vernis, Laurence
    Huang, Meng-Er
    Legraverend, Michel
    Faye, Gerard
    JOURNAL OF BIOTECHNOLOGY, 2015, 195 : 30 - 36
  • [28] Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle
    Golsteyn, RM
    CANCER LETTERS, 2005, 217 (02) : 129 - 138
  • [29] Yeast as a model system to screen purine derivatives against human CDK1 and CDK2 kinases
    Mayi, T.
    Huang, M. E.
    Vernis, L.
    Legraverend, M.
    Faye, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S80 - S80
  • [30] Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer
    Kim, S. J.
    Nakayama, S.
    Miyoshi, Y.
    Taguchi, T.
    Tamaki, Y.
    Matsushima, T.
    Torikoshi, Y.
    Tanaka, S.
    Yoshida, T.
    Ishihara, H.
    Noguchi, S.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 68 - 72